AquaBounty Technologies (AQB) Stock Analysis

What AquaBounty Technologies does

AquaBounty Technologies, Inc. is a biotechnology firm dedicated to boosting productivity within the commercial fish farming sector across the United States and Canada. The company's research initiatives delve into genetics, genomics, fish health, and nutrition. Its flagship offering is AquAdvantage Salmon, a genetically engineered Atlantic salmon intended for human consumption. Beyond this, AquaBounty also supplies conventional Atlantic salmon, along with salmon eggs, juvenile fish (fry), and various byproducts. Established in 1991, the firm maintains its headquarters in Maynard, Massachusetts. It operated under the name Aqua Bounty Farms, Inc. until its rebranding in June 2004.

Key metrics

ETFs linked to AQB

Broad-market and Consumer Defensive sector ETFs an investor holding AquaBounty Technologies is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how AQB fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Frequently asked questions

What is the ticker symbol for AquaBounty Technologies?

AquaBounty Technologies trades under the ticker AQB on NASDAQ.

Which exchange is AQB listed on?

AQB is listed on NASDAQ.

What sector does AquaBounty Technologies operate in?

AquaBounty Technologies is classified in the Consumer Defensive sector (Agricultural Farm Products industry).

How can PortView help analyze AQB in a portfolio?

PortView shows AQB's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.